Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A gut (microbiome) feeling about the brain.
Insights into the Pathogenesis and Treatment of Krabbe Disease.
Disability and progression in Afro-descendant patients with multiple sclerosis.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors.
Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation.
Regenerative Capacity of Macrophages for Remyelination.
Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study.
Anti-thyroid antibodies and thyroid function in neuromyelitis optica spectrum disorders.
Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program.
Best Practices for Intrathecal Baclofen Therapy: Patient Selection.
Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.
Myelinated fibers of the mouse spinal cord after a 30-day space flight.
Benefit-Risk Analysis for Decision-Making: An Approach.
Multiple Sclerosis in Pediatrics: Current Concepts and Treatment Options.
Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid.
Serum concentration of CD40L is elevated in inflammatory demyelinating diseases.
Behavioral and electromyographic assessment of oxaliplatin-induced motor dysfunctions: evidence for a therapeutic effect of allopregnanolone.
Structure-Based Development of an Affinity Probe for Sirtuin 2.
Neurotropin attenuates local inflammatory response and inhibits demyelination induced by chronic constriction injury of the mouse sciatic nerve.
Multiple Approaches to Multiple Sclerosis (and Other Demyelinating Diseases).
Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies.
Enrolling and keeping participants in multiple sclerosis self-management interventions: A systematic review and meta-analysis.
MRI in the evaluation of pediatric multiple sclerosis.
Pediatric optic neuritis.
Pages
« first
‹ previous
…
775
776
777
778
779
780
781
782
783
…
next ›
last »